The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predictive value of BRCA1 haplotype for trabectedin efficacy in patients with advanced soft-tissue sarcoma.
Audrey Laroche
No relevant relationships to disclose
Delphine Garbay
No relevant relationships to disclose
Vanessa Chaire
No relevant relationships to disclose
Valerie Le Morvan
No relevant relationships to disclose
Agnes Neuville
No relevant relationships to disclose
François Bertucci
No relevant relationships to disclose
Sébastien Salas
No relevant relationships to disclose
Roberta Sanfilippo
No relevant relationships to disclose
Philippe Pourquier
No relevant relationships to disclose
Antoine Italiano
No relevant relationships to disclose